PATENT CLAIM ANALYSIS

Application Number: 15920191
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
Methods of using viruses labeled with alkyne-modified biomolecules, such as fatty acids, carbohydrates and lipids, to treat a plant, an insect or an animal infected with a virus or to increase the infectivity of a virus, such as the human immunodeficiency virus, are provided. Also provided are methods of labeling a virus, such as human immunodeficiency virus, with an alkyne-modified biomolecule, such as a fatty acid, a carbohydrate, or an isoprenoid lipid. The viruses labeled with alkyne-modified biomolecules may be combined with a pharmaceutically acceptable excipient to produce a pharmaceutical composition, optionally containing another anti-viral agent and/or a delivery agent, such as a liposome.

Claim (Index 86):
The virus of  claim 83 , wherein the virus is an adenovirus, a paramyoxovirus, a retrovirus or a baculovirus.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 2.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14374404', '15671360', '13192959', '14831220', '15834639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.752682289863174
- 35 USC 102 Novelty (BERT): 0.5468567928460567
- Combined Prediction Score: 0.7320997401614623
- Mean Citation Score: 316.491524
- Max Citation Score: 404.0195
- Similarity Product: 321.33614484527715

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test